Toll-like receptors (TLRs) are a class of proteins that play an essential role in the innate immune system. They are a type of pattern recognition receptor (PRR) that recognize molecules that are broadly shared by pathogens but distinguishable from host molecules, known as pathogen-associated molecular patterns (PAMPs). Among the various TLRs, TLR5 is unique in its ability to recognize flagellin, the principal component of bacterial flagella, which are whip-like appendages that many bacteria use for locomotion.
TLR5 activators are molecules that can stimulate the TLR5 receptor, leading to its activation. Given that TLR5 primarily recognizes flagellin, most natural TLR5 activators are found in or mimic components of bacterial flagellin. Once activated, TLR5 initiates a cascade of intracellular signaling events, primarily through the MyD88-dependent pathway. This leads to the activation of transcription factors like nuclear factor-kappa B (NF-κB), which then induces the production of various cytokines and chemokines. These molecules subsequently modulate the inflammatory response, aiding the host in countering bacterial infections. It's worth noting that not all bacteria possess flagella, and therefore, not all bacteria can activate TLR5. The specificity of TLR5 for flagellin makes TLR5 activators of significant interest in understanding host-pathogen interactions, especially in infections involving flagellated bacteria.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
Resiquimod is an imidazoquinoline compound that can activate various TLRs, potentially leading to a broader upregulation of the immune response, including the expression of TLR5. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is another member of the imidazoquinoline family and has been shown to activate certain TLRs. Like Resiquimod, it may influence TLR5 expression indirectly via a broader immune response. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly(I:C) is a synthetic analog of double-stranded RNA. It primarily targets TLR3, but its immune-activating properties might indirectly influence TLR5 expression. | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
A synthetic tripalmitoylated lipopeptide, which primarily activates TLR1/2. Its general immune-activating properties might indirectly influence TLR5 expression. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
A member of the imidazoquinoline family like Resiquimod and Imiquimod. It might indirectly influence TLR5 expression by activating other TLRs and inducing a broader immune response. | ||||||
Zymosan | 9010-72-4 | sc-296863 sc-296863A | 100 mg 1 g | $99.00 $599.00 | 1 | |
Derived from yeast cell walls, Zymosan primarily targets TLR2. Its immune-stimulatory properties might have an indirect effect on TLR5 expression. | ||||||